3649 studies found for:    "Depressive Disorder"
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy Study in Patients With Major Depressive Disorder
Conditions: Depressive Disorder;   Major Depressive Disorder (MDD);   Major Depressive Episode
Interventions: Drug: GSK163090 Tablets;   Drug: GSK163090 Placebo Tablets
2 Active, not recruiting Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Intervention: Drug: OPC-34712 + ADT
3 Recruiting A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: Brexpiprazole;   Drug: Seroquel XR;   Drug: Placebo
4 Completed Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: OPC-34712 + ADT;   Drug: Placebo + ADT
5 Completed Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: OPC-34712 + ADT;   Drug: Placebo + ADT
6 Recruiting Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: Placebo + ADT;   Drug: Brexpiprazole +ADT
7 Recruiting Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial
Conditions: Major Depressive Disorder;   Major Depressive Disorder, Recurrent, Unspecified;   Major Depressive Disorder, Single Episode, Unspecified
Interventions: Drug: Escitalopram oxalate;   Device: transcranial direct current stimulation
8 Withdrawn Brain Imaging, Genetics and Treatment for Major Depression
Conditions: Depressive Disorder;   Depressive Disorder, Major;   Depression
Intervention: Other: Citalopram
9 Completed Study Of GW679769 In Major Depressive Disorder
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: GW679769
10 Not yet recruiting Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)
Conditions: Major Depressive Disorder;   Major Depressive Episode
Intervention: Drug: Venlafaxine  extended release
11 Terminated Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
Conditions: Hepatitis C;   Depressive Disorder, Major;   Depressive Disorder;   Depression;   HIV Infections
Interventions: Behavioral: Hepatitis C educational support groups;   Behavioral: Cognitive Behavioral Therapy skills based group sessions
12 Completed Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: GW679769
13 Terminated Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features
Conditions: Major Depressive Disorder;   Major Depressive Disorder w/ Psychotic Features;   Metabolic Syndrome
Intervention:
14 Not yet recruiting Study to Treat Major Depressive Disorder (MDD) With a New Medication
Conditions: Major Depressive Disorder;   Depression
Intervention: Drug: ezogabine
15 Completed Evaluating Brain Responses to Facial Expressions in Major Depressive Disorder
Conditions: Current Major Depressive Disorder;   Healthy;   Remitted Major Depressive Disorder
Intervention:
16 Completed N-methylglycine (Sarcosine) Treatment for Depression
Conditions: Major Depressive Disorder;   Depression;   Major Depression
Interventions: Drug: citalopram;   Drug: sarcosine
17 Terminated Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder
Conditions: Depression;   Depressive Disorder
Interventions: Device: Cortical Stimulation;   Device: Sham
18 Completed A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression
Conditions: Depressive Disorder;   Depressive Disorder, Major;   Depression
Intervention: Drug: risperidone
19 Unknown  Using Neuroimaging to Investigate Major Depressive Disorder
Conditions: Major Depressive Disorder;   Depression;   Anxiety
Intervention:
20 Withdrawn Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive Disorder
Conditions: Depression;   Major Depressive Disorder
Intervention: Biological: RO4995819

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years